[HTML][HTML] RNA-binding proteins in tumor progression
H Qin, H Ni, Y Liu, Y Yuan, T Xi, X Li… - Journal of hematology & …, 2020 - Springer
RNA-binding protein (RBP) has a highly dynamic spatiotemporal regulation process and
important biological functions. They are critical to maintain the transcriptome through post …
important biological functions. They are critical to maintain the transcriptome through post …
[HTML][HTML] Artificial intelligence (AI) and big data in cancer and precision oncology
Artificial intelligence (AI) and machine learning have significantly influenced many facets of
the healthcare sector. Advancement in technology has paved the way for analysis of big …
the healthcare sector. Advancement in technology has paved the way for analysis of big …
[HTML][HTML] Neoantigens: promising targets for cancer therapy
Recent advances in neoantigen research have accelerated the development and regulatory
approval of tumor immunotherapies, including cancer vaccines, adoptive cell therapy and …
approval of tumor immunotherapies, including cancer vaccines, adoptive cell therapy and …
Alternative mRNA splicing in cancer immunotherapy
L Frankiw, D Baltimore, G Li - Nature Reviews Immunology, 2019 - nature.com
Immunotherapies are yielding effective treatments for several previously untreatable
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
[HTML][HTML] Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development
RNA editing and splicing are the two major processes that dynamically regulate human
transcriptome diversity. Despite growing evidence of crosstalk between RNA editing …
transcriptome diversity. Despite growing evidence of crosstalk between RNA editing …
Crosstalk between m6A modification and alternative splicing during cancer progression
ZM Zhu, FC Huo, J Zhang, HJ Shan… - Clinical and …, 2023 - Wiley Online Library
Abstract Background N6‐methyladenosine (m6A), the most prevalent internal mRNA
modification in eukaryotes, is added by m6A methyltransferases, removed by m6A …
modification in eukaryotes, is added by m6A methyltransferases, removed by m6A …
[HTML][HTML] Alternative splicing in angiogenesis
Alternative splicing of pre-mRNA allows the generation of multiple splice isoforms from a
given gene, which can have distinct functions. In fact, splice isoforms can have opposing …
given gene, which can have distinct functions. In fact, splice isoforms can have opposing …
[HTML][HTML] Update on uveal melanoma: Translational research from biology to clinical practice
MA Ortega, O Fraile-Martinez… - International …, 2020 - spandidos-publications.com
Uveal melanoma is the most common type of intraocular cancer with a low mean annual
incidence of 5-10 cases per million. Tumours are located in the choroid (90%), ciliary body …
incidence of 5-10 cases per million. Tumours are located in the choroid (90%), ciliary body …
[HTML][HTML] An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks
J Ramírez-Moya, C Miliotis, AR Baker, RI Gregory… - Molecular Cancer, 2021 - Springer
Background Adenosine deaminases acting on RNA (ADARs) modify many cellular RNAs by
catalyzing the conversion of adenosine to inosine (A-to-I), and their deregulation is …
catalyzing the conversion of adenosine to inosine (A-to-I), and their deregulation is …
[HTML][HTML] Alternative splicing: expanding the landscape of cancer biomarkers and therapeutics
Alternative splicing (AS) is a critical post-transcriptional regulatory mechanism used by more
than 95% of transcribed human genes and responsible for structural transcript variation and …
than 95% of transcribed human genes and responsible for structural transcript variation and …